🔎 Trials Near Me

Akèy › Nefrit Lupus › Massachusetts

Etid klinik pou Nefrit Lupus nan Massachusetts

8 etid pou Nefrit Lupus ap chèche patisipan nan sit nan Massachusetts.

Vil nan Massachusetts

Tèks ofisyèl etid la (Anglè)

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

  • Brigham and Womens Hosp Harvard Med School, Boston
Ap rekriteFaz 2
Laj 18 a 100 · Tout sèks · Mizajou Oct 1, 2026 · NCT05268289

A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

  • Research Site, Boston
Ap rekriteFaz 1/2
Laj 18 a 70 · Tout sèks · Mizajou Sep 10, 2026 · NCT06897930

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

  • Boston Medical Center, Boston
Ap rekriteFaz 1
Laj 18 a 70 · Tout sèks · Mizajou Aug 28, 2026 · NCT06925542

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

  • Tufts Medical Center, Boston
  • Massachusetts General Hospital, Boston
  • Boston Children's Hospital, Boston
  • ak 2 plis
Ap rekriteFaz 1/2
Laj 18 a 65 · Tout sèks · Mizajou Aug 26, 2026 · NCT06121297

A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

  • Brigham And Womens Hospital, Boston
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT07115745

A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)

  • Nkarta Investigational Site, Worcester
Ap rekriteFaz 1/2
Laj 18 a 75 · Tout sèks · Mizajou Jun 4, 2026 · NCT06557265

Dapagliflozin in Active Lupus Nephritis

  • Massachusetts General Hospital, Boston
  • Brigham and Women's Hospital, Boston
Ap rekriteFaz 4
Laj 18 a 70 · Tout sèks · Mizajou May 26, 2026 · NCT07323524

Lupus Landmark Study: A Prospective Registry and Biorepository

  • Brigham and Women's Hospital, Boston
  • University of Massachusetts Memorial Health, Worcester
Ap rekriteEtid obsèvasyon
Laj 18 a 110 · Tout sèks · Mizajou Apr 15, 2026 · NCT05934149

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.